Impact of Implementing the Personalized Non-Pharmacological Therapies Method in Facilities for the Elderly
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorCentre Médical Porte Verte
About this trial
To evaluate, by comparison with the classical method, the effectiveness of using the TNmP method in reducing the intensity or frequency of behavioral disorders in elderly people institutionalized in an institution.
Eligibility criteria
Qualifiers
Individuals aged 65 years and older;
Dependent older adults residing in institutional settings, including individuals under legal guardianship or trusteeship, who have been recently admitted to the facility;
Individuals presenting a neurocognitive disorder associated with disruptive cognitive and psychological symptoms (CPS), such as agitation, oppositional behavior, or excessive wandering;
Free and informed consent to participate in the study, signed by the participant or their legal representative.
Disqualifiers
Lack of affiliation to a health insurance or social security scheme;
Life expectancy of less than three months;
Inability to obtain a signed informed consent form from the resident or their legal representative
Trial design
Treatments tested in this trial
- TNmP
Treatment groups
226 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov